 William Goolsbee resigned as Sarepta Therapeutics Incs chairman the company said Thursday the latest twist in an executive drama that has roiled the biotechnology company over the past month Mr Goolsbees resignation comes after he placed limits on Chief Executive Chris Garabedians authority in regulatory and medical affairs including a ban on his attendance at meetings with the Food and Drug Administration The Wall Street Journal reported 